<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02389803</url>
  </required_header>
  <id_info>
    <org_study_id>rmc067614ctil</org_study_id>
    <nct_id>NCT02389803</nct_id>
  </id_info>
  <brief_title>Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys</brief_title>
  <official_title>Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study design:

      Double blind, randomized, placebo controlled study. Participants will be randomly assigned
      either to the intervention group or the placebo control group. Randomization for the two
      study groups will be made in a ratio of 1:1.

      The primary objective of the study is to assess the effect of 6-12 months treatment with
      nutritional supplementation standardized formula, in short and lean boys adolescents on
      weight Standard Deviation Score (SDS) and height SDS The Secondary Objectives of the study
      are to assess the effect of 6-12 months treatment with nutritional supplementation
      standardized formula, in short and lean boys adolescents on BMI SDS, growth velocity, time to
      puberty, quality of life and self-esteem The study will continue for 6 months of intervention
      versus active placebo, with additional optional 6 months (an extension period), in which
      participants at both groups, the intervention and the placebo, will be offered to continue
      their participation in the study with the study supplement. All analyses of the effect's on
      primary and secondary outcome measurements will take into account the consumption rate of the
      study formula/placebo
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight SDS (standard deviation score)</measure>
    <time_frame>At 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Height SDS (standard deviation score)</measure>
    <time_frame>At 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight SDS (standard deviation score)</measure>
    <time_frame>At 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Height SDS (standard deviation score)</measure>
    <time_frame>At 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMI SDS (standard deviation score)</measure>
    <time_frame>At 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI SDS (standard deviation score)</measure>
    <time_frame>At 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth velocity</measure>
    <time_frame>At 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth velocity</measure>
    <time_frame>At 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At 12 months</time_frame>
    <description>Quality of life measured by Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At 6 months</time_frame>
    <description>Quality of life measured by Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-esteem (Self-Esteem Questionnaire)</measure>
    <time_frame>At 12 months</time_frame>
    <description>Self-esteem measured by Self-Esteem Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-esteem (Self-Esteem Questionnaire)</measure>
    <time_frame>At 6 months</time_frame>
    <description>Self-esteem measured by Self-Esteem Questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to puberty initiation (Duration of time until testicular volume is at tanner stage &gt;=2)</measure>
    <time_frame>At 12 months</time_frame>
    <description>Duration of time until testicular volume is at tanner stage &gt;=2</description>
  </other_outcome>
  <other_outcome>
    <measure>Sleep assessment Questionnaire</measure>
    <time_frame>At 12 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Sleep assessment Questionnaire</measure>
    <time_frame>At 6 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Physical Activity Questionnaire</measure>
    <time_frame>At 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Study Participation Questionnaire</measure>
    <time_frame>At 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Study Participation Questionnaire</measure>
    <time_frame>At 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Family Eating and Activity Habits Questionnaire</measure>
    <time_frame>At 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Family Eating and Activity Habits Questionnaire</measure>
    <time_frame>At 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Parents Stands Towards Healthy Lifestyle Questionnaire</measure>
    <time_frame>At 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Parents Stands Towards Healthy Lifestyle Questionnaire</measure>
    <time_frame>At 12 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Growth Problem</condition>
  <condition>Low Weight</condition>
  <condition>Short Stature</condition>
  <arm_group>
    <arm_group_label>Nutritional supplementation standardized formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Powder added to water, containing about 25% of recommended Daily Recommended Intake (DRI) for Calories, high protein (25% of calories) and multi vitamin and mineral (25%-100% of DRI for recommended daily allowance (RDA) or adequate intake )</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Low caloric formula (Powder added to water), without added vitamins and mineral</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional supplementation standardized formula</intervention_name>
    <description>Powder added to water, containing about 25% of recommended DRI for Calories, high protein (25% of calories) and multi vitamin and mineral (25%-100% of DRI for recommended daily allowance (RDA) or adequate intake )</description>
    <arm_group_label>Nutritional supplementation standardized formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo comparator</intervention_name>
    <description>Low caloric formula (Powder added to water), without added vitamins and minerals</description>
    <arm_group_label>Placebo comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Boys aged ≥10years old

          -  Prepubertal - Tanner stage 1 (gonadarche) (testicular volume&lt;4)

          -  Height and weight ≤ 10th percentile for age and gender.

          -  Height-SDS ≥ -2.5 SDS

          -  BMI-SDS&gt;-3 SDS

          -  Low proportion between weight and height

          -  Signing inform consent forms

        Exclusion Criteria:

          -  Diagnosis of Growth Hormone (GH) Deficiency or treatment with GH

          -  Any known chronic disease or dysmorphic syndrome including: bone diseases, organic
             brain diseases, neurological disease, past or current malignancy, chronic cardiac,
             renal or pulmonary problems

          -  Any known gastrointestinal disease including malabsorption

          -  Any known organic reason for growth retardation
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moshe Phillip, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schneider Children's Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mo Phillip, Prof</last_name>
    <phone>972-3-9253282</phone>
    <email>mosheph@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alona Hamou, Msc</last_name>
    <phone>972-3-9253778</phone>
    <email>alonah@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Be'er Sheva`</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eli Hershkovitz, MD</last_name>
      <email>elih@bgu.ac.il</email>
    </contact>
    <investigator>
      <last_name>Eli Hershkovitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schneider Medical Center</name>
      <address>
        <city>Petach- Tikva</city>
        <zip>49202</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moshe :Phillip, Prof.</last_name>
      <phone>972-3-9253282</phone>
      <email>moshph@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Alona Hamou, MSc</last_name>
      <phone>972-3-9253778</phone>
      <email>alonah@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ravital Nimri, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tal Oron, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sharon Demol, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shlomit Shalitin, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ariel Tenennbaum, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liat De-vries, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liora Lazar, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Avivit Brener, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel Bello, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Mouler, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Naama Fish, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assaf Harofe Medical Center</name>
      <address>
        <city>Rishon Letsiyon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianna Rachmiel, MD</last_name>
      <email>Rmarianna@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Marianna Rachmiel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2015</study_first_submitted>
  <study_first_submitted_qc>March 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2015</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

